Semaglutide is approved as Ozempic (diabetes, December 2017), Wegovy (obesity, June 2021), and, in oral form, the Ozempic pill (diabetes, 2026, which reformulated and renamed Rybelsus) and the Wegovy pill (weight, December 2025)
If you get any side effects, talk to your doctor or pharmacist
It is important to note that many of the studies that examined the efficacy of lipoic acid in the treatment of diabetic neuropathy have been primarily conducted by one German research group and funded by the manufacturer of lipoic acid in Germany (82)
The GLP-1 drugs on the market today are mostly peptide-based injectables
[4] Reported side effects in human users, primarily from observational reports and clinical anecdote rather than controlled studies, include mild nausea, dizziness, and injection site irritation
Third party testing and strict quality controls, so whats on the label is exactly whats in every scoop